...
首页> 外文期刊>Analytical chemistry >Compatible spectrophotometric methods for the determination of two antihypertensive mixtures containing hydrochlorothiazide in pharmaceutical preparations
【24h】

Compatible spectrophotometric methods for the determination of two antihypertensive mixtures containing hydrochlorothiazide in pharmaceutical preparations

机译:兼容的分光光度法测定药物制剂中两种含氢氯噻嗪的降压混合物

获取原文
获取原文并翻译 | 示例
           

摘要

Simple, rapid, accurate and precise spectrophotometric methods have been developed and subsequently validated for simultaneous determination of telmisartan (I) and bisoprolol fumarate (II), separately, in binary mixtures with hydrochlorothiazide (HCTZ). Isosbestic point technique was the first method adopted for determination of (I) and (HCTZ) mixture, by utilizing zero-order and first derivative spectra (D~1) at 266.0 and 323.0 nm for the total concentration and (I), respectively. The second method was ratio subtraction technique used for determination of bisoprolol fumarate in presence of hydrochlorothiazide at 224.4 nm, using hydrochlorothiazide (10 μg.ml~(-1)) as a divisor. Dual wavelength technique was the third way used for hydrochlorothiazide determination in presence of bisoprolol fumarate, by using the absorbance difference at 266.0 and 277.8 nm. The proposed methods have been validated according to International Conference Harmonization (ICH) guidelines and were found to be valid and suitable for the assay of the cited drugs in raw materials and in combined dosage forms. All the obtained results for the mentioned drugs were statistically compared with those of reference and United State Pharmacopeia for [(I) and (HCTZ)] and [(II) and (HCTZ)] and no significant differences were found.
机译:已经开发了简单,快速,准确和精确的分光光度法,随后经过验证,可同时测定与氢氯噻嗪(HCTZ)的二元混合物中的替米沙坦(I)和富马酸比索洛尔(II)。等渗点技术是用于确定(I)和(HCTZ)混合物的第一种方法,该方法分别利用总浓度和(I)的零阶和一阶导数光谱(D〜1)在266.0和323.0 nm处进行。第二种方法是比率减法,使用氢氯噻嗪(10μg.ml〜(-1))作为除数,用于在224.4 nm氢氯噻嗪存在下测定富马酸比索洛尔。在富马酸比索洛尔存在下,双波长技术是测定氢氯噻嗪的第三种方法,方法是利用266.0和277.8 nm处的吸光度差。所提出的方法已经根据国际会议协调(ICH)指南进行了验证,并且被发现是有效的并且适合于对原料药和组合剂型中引用的药物进行测定。将上述药物获得的所有结果与[[I]和(HCTZ)]和[[II]和(HCTZ)]的参考药和美国药典进行统计学比较,未发现显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号